Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples. 2022

Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
Department of Gynecology, Sapporo Medical University, 291, West 16, South 1, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan. 0407noriko@gmail.com.

BACKGROUND Human papillomavirus (HPV) testing using self-collected vaginal samples and urine samples is convenient and effective for improving the screening rate. But, to serve as an alternative cervical cancer screening technique, such tests must offer sensitivity equivalent to the HPV testing of physician-collected cervical samples. To examine the effectiveness of HPV testing using self-collected samples and urine samples, we compared the results of HPV testing using these samples with those of HPV testing using physician-collected samples and cytological examinations. METHODS The study population included 300 women (age: 20-50 years) with abnormal cervical cytology. The results of HPV testing using self-collected samples and urine samples and physician-collected samples and cervical cytology were compared. RESULTS For all HPV types, the κ-value was 0.773 for physician- and self-collected samples and 0.575 for physician-collected and urine samples. The κ-value for HPV type 16-positive samples was 0.988 for physician- and self-collected samples and 0.896 for physician-collected and urine samples. The κ-value for HPV type 18-positive samples was 0.856 for physician- and self-collected samples and 0.831 for physician-collected and urine samples. For other HPV types, the value was 0.809 for physician- and self-collected samples and 0.617 for physician-collected and urine samples. CONCLUSIONS The obtained results were consistent between physician- and self-collected samples as well as between physician-collected and urine samples. Considering that the agreement rate was particularly high for the high-risk HPV types 16 and 18, HPV testing using physician-collected samples, self-collected samples, and urine samples was equally effective for the types with high carcinogenicity.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010820 Physicians Individuals licensed to practice medicine. Physician
D002578 Uterine Cervical Dysplasia Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE. Cervical Dysplasia,Cervical Intraepithelial Neoplasia,Cervix Dysplasia,Dysplasia of Cervix Uteri,Neoplasia, Cervical Intraepithelial,Cervical Intraepithelial Neoplasia, Grade III,Cervical Intraepithelial Neoplasms,Intraepithelial Neoplasia, Cervical,Cervical Dysplasia, Uterine,Cervical Dysplasias,Cervical Intraepithelial Neoplasm,Cervix Uteri Dysplasia,Cervix Uteri Dysplasias,Dysplasia, Cervical,Dysplasia, Cervix,Dysplasia, Uterine Cervical,Intraepithelial Neoplasm, Cervical,Intraepithelial Neoplasms, Cervical,Neoplasm, Cervical Intraepithelial,Neoplasms, Cervical Intraepithelial
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013048 Specimen Handling Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. Specimen Collection,Collection, Specimen,Collections, Specimen,Handling, Specimen,Handlings, Specimen,Specimen Collections,Specimen Handlings

Related Publications

Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
October 2014, European journal of obstetrics, gynecology, and reproductive biology,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
December 2009, Cancer epidemiology,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
September 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
November 2022, Sexually transmitted diseases,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
July 2021, Cancer research and treatment,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
September 2023, Viruses,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
May 2007, Gynecologic oncology,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
April 2017, The journal of obstetrics and gynaecology research,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
January 2015, Journal of the National Cancer Institute,
Noriko Terada, and Motoki Matsuura, and Shoko Kurokawa, and Yoko Nishimura, and Masato Tamate, and Kyoko Isoyama, and Satoko Yamazaki, and Hiroshi Shimada, and Masahiro Suzuki, and Yuta Tabuchi, and Mizue Teramoto, and Tsuyoshi Saito
April 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Copied contents to your clipboard!